RE: BLIND LEADING THE BLIND2 Sep 2022 09:24
Virosynth in partnership with Volz, significant strides were made, and application technology developed, that facilities the use of Nanosynth nanotechnology within their production facilities, resulting in their being able to manufacture media that is permanently anti-pathogenic.
Introducing these advances to any media manufacture that would like to adopt them.